Xenical orlistat lipase inhibitor data

Researchers presented data at the European Conference on Obesity in Dublin from a randomized, placebo-controlled trial of Xenical in 729 obese patients (BMI 28-43). Patients

Read the full 254 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE